Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Four Leaf Acquisition Corporation Class A Common Stock (FORL)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/28/2025: FORL (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit 5.58% | Avg. Invested days 138 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 11/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 47.23M USD | Price to earnings Ratio 231.6 | 1Y Target Price - |
Price to earnings Ratio 231.6 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta -0.02 | 52 Weeks Range 10.95 - 12.79 | Updated Date 06/28/2025 |
52 Weeks Range 10.95 - 12.79 | Updated Date 06/28/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.05 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin - | Operating Margin (TTM) - |
Management Effectiveness
Return on Assets (TTM) -1.7% | Return on Equity (TTM) 218.28% |
Valuation
Trailing PE 231.6 | Forward PE - | Enterprise Value 49775255 | Price to Sales(TTM) - |
Enterprise Value 49775255 | Price to Sales(TTM) - | ||
Enterprise Value to Revenue - | Enterprise Value to EBITDA -68.48 | Shares Outstanding 2722900 | Shares Floating 1535384 |
Shares Outstanding 2722900 | Shares Floating 1535384 | ||
Percent Insiders - | Percent Institutions 92.77 |
Upturn AI SWOT
Four Leaf Acquisition Corporation Class A Common Stock
Company Overview
History and Background
Four Leaf Acquisition Corporation was a blank check company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. They did not have any specific business combination initially. However, in May of 2022 they signed a merger agreement with Autonomix Medical, Inc. That merger did go through, and the SPAC, Four Leaf, effectively ceased to exist.
Core Business Areas
Leadership and Structure
Prior to the merger, the leadership team would have consisted of the SPAC's management team. After the merger the leadership team is that of Autonomix Medical, Inc.
Top Products and Market Share
Key Offerings
Market Dynamics
Industry Overview
Four Leaf Acquisition Corporation was involved in the special purpose acquisition company (SPAC) industry.
Positioning
Four Leaf Acquisition Corporation's position was as a SPAC searching for a target company to merge with.
Total Addressable Market (TAM)
TAM for SPACs fluctuates based on investor sentiment and market conditions. Four Leaf's position within the TAM was as one of many SPACs seeking a target.
Upturn SWOT Analysis
Strengths
Weaknesses
- No operating history prior to merger.
- Dependence on management team's ability to identify and complete a business combination.
Opportunities
- Ability to acquire a high-growth company.
- Access to public markets for the target company.
Threats
- Inability to find a suitable target.
- Changing regulatory landscape for SPACs.
- Market volatility.
Competitors and Market Share
Key Competitors
Competitive Landscape
Four Leaf Acquisition Corporation's competitive advantage lay in its management team's expertise and network.
Growth Trajectory and Initiatives
Historical Growth: The SPAC itself did not have historical growth.
Future Projections: Future projections depend entirely on the performance of the merged entity (Autonomix Medical, Inc.).
Recent Initiatives: The most recent initiative was the merger with Autonomix Medical, Inc.
Summary
Four Leaf Acquisition Corporation was a SPAC that successfully merged with Autonomix Medical, Inc. Its success hinges on the performance of the target company. SPACs are dependent on their management team to identify and successfully complete a merger, which Four Leaf was able to do. It faced the typical risks associated with SPACs including finding the right target and market volatility. Future prospects are tied to the performance of Autonomix Medical, Inc.
Similar Stocks
Sources and Disclaimers
Data Sources:
- SEC filings
- Company press releases
- Financial news outlets
Disclaimers:
The information provided is for informational purposes only and should not be considered investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Four Leaf Acquisition Corporation Class A Common Stock
Exchange NASDAQ | Headquaters Los Altos, CA, United States | ||
IPO Launch date 2023-05-16 | Interim CEO & Chairman Mr. Bala Padmakumar | ||
Sector Financial Services | Industry Shell Companies | Full time employees - | Website https://www.fourleaf.investment |
Full time employees - | Website https://www.fourleaf.investment | ||
Four Leaf Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses in the Internet of Things sector. The company was incorporated in 2022 and is based in Los Altos, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.